Differential metabolism of human VLDL according to content of apoE and apoC-III

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 9, 2001, Pages 1494-1500

  Tomiyasu, Koji ^a,c   Walsh, Brian W ^b   Ikewaki, Katsunori ^a,d   Judge, Helena ^a   Sacks, Frank M ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c School of Medicine ^*

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein B; Apolipoprotein C III; Apolipoprotein E; Lipoproteins; Metabolism

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CATABOLISM; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; NORMAL HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; ULTRACENTRIFUGATION;

EID: 0035572891     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0901.094489     Document Type: Article

References (34)

1. Apolipoprotein composition as the basis for classifying plasma lipoproteins: Characterization of ApoA- and ApoB-containing lipoprotein families
2. The receptor binding domain of human apolipoprotein: Monoclonal antibody inhibition of binding
3. Expression of apolipoprotein B epitopes in lipoproteins: Relationship to conformation and function
4. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins
5. The influence of apolipoprotein E on the interactions between normal human very low density lipoproteins and U937 human macrophages: Heterogeneity among persons
6. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and CIII
7. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial
8. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein
9. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor
10. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans
11. Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: Modulation by apolipoprotein E and apolipoprotein C
12. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins
13. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
14. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women
15. Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E
16. Isolation and characterization of two distinct species of human very low density lipoproteins lacking apolipoprotein E
17. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: Importance for apolipoprotein E function
18. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein
19. Assembly of very low density lipoproteins in rat liver: A study of nascent particles recovered from the rough endoplasmic reticulum
20. Recycling of apolipoprotein B in mouse liver
21. The HepG2 extracellular matrix contains separate heparinase- and lipid-releasable pools of ApoE: Implications for hepatic lipoprotein metabolism
22. High density lipoprotein subfractions isolated by heparin-Sepharose affinity chromatography and their role in cholesteryl ester transfer to very low density lipoproteins
23. Dynamics of apolipoprotein E metabolism in humans
24. A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein
25. Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects
26. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway
27. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice: Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E
28. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat: Opposing effects of homologous apolipoprotein E and individual C apoproteins
29. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins C III and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo
30. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
31. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo
32. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipidemic subjects
33. Familial apolipoprotein E deficiency
34. VLDL, Apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial